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formly around a cell may produce less contraction as compared 
to pulling fibrils at elongated ends of normal cells. Normal 
fibroblasts may pull collagen fibr ils, which forces liquid m edia 
from between collagen fibrils from two points very distant from 
one another. EBdr fibroblasts may pull co llagen fibrils at nu-' 
merous points relatively close to one another. The overall effect 
with EBdr cells is less movement of co llagen fibrils, resulting in 
reduced degree of co·ntraction. 
Another view of differences between EBdr and normal fibro-
blasts incorporated in to a collagen matrix may be related to 
organization of that matrix. Normal fibroblasts, morphologi-
cally, are more organized. They have an elongated flattened-
out shape and two loci of collagen fibril attachments. EBdr 
fibroblasts are less organized, have a rounded, more spherical 
shape, and numerous loci of attachments to collagen fibrils. 
The more ra ndom attachment of EBdT fibroblasts to collagen 
matrix may produce a more random organization of the collagen 
matrix. 
EBdr fibroblasts will contract FPCL but with retarded degree 
and rate of contraction. It takes 10 X W' EBdr fibrob lasts to 
contract FPCL as well as 2.5 x 10" normal fibroblasts. Normal 
fibroblasts with their flattened elongated shapes have a greater 
surface area as compared to EBdr fibroblasts with their spher-
ical shape. This reduced surface area of EBdr fibroblasts in 
collagen matrix may be related to the 4-fold increase in cell 
number necessary for contraction, compared to normal fibro-
blasts. Abnormal EBdJ' cellular morphology may be related to 
cell surface membrane or microtubular assembly anomalies. 
Addition of colchicine to normal FPCL will inhibit or retard 
contraction [7]. Harris and Krane have shown that the addition 
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of colchicine to fibroblasts in tissue cul tlU'e stimulates collagen-
ase synthesis [8]. EBill fibroblasts synthesize more collagenase 
and have a n unusual cell morphology. The addition of colchi-
cine to fibroblasts in culture both inhibits FPCL contraction 
and stimulates collagenase production. These kinds of studies 
should help defin e more clearly the subcellular sites where the 
EBdr genotype is expressed in aberrant cell behavior and may 
provide insights into the phenotypic presentation of patients 
with this disorder. 
REFERENCES 
1. Gedde-Dah l T: Epidermolys is Bu llosa. A Clinical, Genetic a nd 
Epidemio logical Study. Baltimore, Johns Hopkins P ress, 1971 
2. Pearson RW: Studies on the pathogenesis of epidermolysis bu llosa. 
J Invest Dermatol 39:551-575, 1962 
3. Briggaman HA, Wheeler CE: Epidermolysis bu llosa dystrophica-
recess ive; a possible role of anchoring fibril s in the pathogenesis. 
J Invest Dermatol 65:203-211, 1975 
4. Bauer EA, Eisen AZ: Recessive epidermolysis bullosa. Evidence for 
increased collagenase as a genetic characteristic in ce ll cul t lLl·es . 
J Exp Med 148:1378-1387, 1978 
5. Bauer EA: Recessive dystrophic epidermolysis bu llosa. Evidence 
for an a ltered collagenase in fibroblast cu ltures. Proc Natl Acad 
Sci USA 74:4646-4650, 1977 
6. Valle K-J, Bauer EA: Enhanced biosynthesis of human skin colla-
genase in fibroblast cul tures from recessive dystrophic epider-
molysis bullosa. J Clin Invest 66:176-187, 1980 
7. Bell E, Ivarsson B, M errill C: Production of a tissue- like structure 
by contraction of collagen lattices by human fibrob lasts of d iffer-
ent proliferative potential in vitro. Proc Nat! Acad Sci USA 
76:1274-1278, 1979 
8. Harris ED Jr, Krane SM: Effects of colchicine on collagenase in 
cultures of rheumatoid synovium. Arthritis Hheum 14:669-684, 
1971 
Vol. 80, No.1 
Printed ill. U.S.A. 
Characterization of T-Cell Subpopulations in Skin and Peripheral Blood 
of Patients with Cutaneous T-Cell Lymphomas and Benign Inflammatory 
Dermatoses 
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Using a series of monoclonal antibodies, the distribu-
tion of T-cell sUbpopulations in the skin and peripheral 
blood was investigated in 21 patients with a cutaneous 
T-cell lymphoma and 14 patients with benign inflam-
matory dermatoses, histologically characterized by a 
bandlike mononuclear infiltrate, e.g., atopic dermatitis, 
chronic eczema, and lichen planus. In Sezary's syndrome 
the large majority of the neoplastic cells, both in the skin 
and the peripheral blood, reacted with Leu-I, Leu-3a, 
OKT3, OKT4, and TA-1 antisera (T helper/inducer phe-
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Abbreviations: 
COP: cyclophosphamide, vincristin (Oncovin), prednisone 
notype). The cutaneous infiltrates in mycosis fungoides 
showed a predominance of Leu-3a\ OKT4+ cells (T 
helper /inducer phenotype), varying numbers ofLeu-2a +, 
OKT8+ cells (T cytotoxic/suppressor phenotype), and, in 
contrast to Sezary's syndrome, not only large numbers 
of nondendritic HLA-DR+ cells (probably activated T-
cells) but also many dendritic nonlymphoid cells ex-
pressing HLA-DR and/ or OKT6 antigens, which presum-
ably represent cells of the Langerhans cell/interdigitat-
CTLC: cutaneous T-cell lymphoma 
DAB: d iaminobenzidine 
EN: neLII·amidase·treated uncoated sheep erythrocyte 
FCS: fetal calf serum 
MF: mycosis fungo ides 
PAP: peroxidase antiperoxidase 
PBS: phosphate-buffered saline 
SS: Sezary syndrome 
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ing reticulum cell series. However, the number of HLA-
DR+ cells in the peripheral blood was not increased. In 
the advanced stages of mycosis fungoides a loss of cer-
tain T-cell antigens (Leu-I, OKT3, and/or Leu-3a and 
OKT4) was observed both in the skin and p eripheral 
blood. The distribution of T-cell subsets, OKT6+ and 
HLA-DR+ cells in the skin and peripheral blood of pa-
tients with atopic dermatitis and chronic eczema was 
similar as compared to the early stages of mycosis fun-
goides. These results indicate that the monoclonal anti-
bodies used in the present study have limited value in 
discriminating between the early stages of mycosis fun-
goides and benign inflammatory dermatoses. However, 
the loss of reactivity with some of these anti-T-cell anti-
sera in patients with well-established mycosis fungoides 
may have prognostic significance. 
In recen t years it has been demonstrated that T -Iymphocytes 
predominate in the cutaneous infiltrates of many benign and 
malignant dermatologic disorders. The various methods used 
thus far, included rosetting techniques [1,2], enzyme histochem-
istry with a1pha-naphtyl acetate esterase [3,4], and immunohis-
tochemical techniques using specific ant isera against human T-
lymphocyte smface antigens [5-7]. Very recently the develop-
ment of monoclonal antibod ies directed against different T-cell 
surface a ntigens has enabled characterization of different sub-
sets of T lymphocytes. The T-cell natme of the cutaneous 
infil trates in mycosis fungoides (MF) has been well established 
[4,5,7] and has contributed to the concept of cutaneous T-cell 
lymphomas (CTCL) [8]. However, histologic criteria for the 
diagnosis of early MF are controversial [9,l0]. The predomi-
nantly T-Iymphocytic bandlike infiltrate with varying numbers 
of hyperchromatic cerebriform mononuclear cells observed in 
the early stages of MF may also be found in chl"Onic benign 
skin lesions [10]. Therefore in om department advanced tech-
niques such as DNA cytophotometry [11] and morphometry 
(12] are used to facili tate the diagnosis of early MF. 
In t he present study we investigated whether characterization 
of different T-cell subsets in the skin a nd the peripheral blood 
can provide additional criteria for differentiating early MF from 
benign int1ammatory dermatoses, histologically characterized 
by a bandlike mononuclear infil trate, and whether it can give 
better insight into the pathogenesis of these condit ions. 
MATERIALS AND METHODS 
Patien.ts 
Two groups of patients were ilwes tigated in this study. The first 
group consisted of 21 patients wi th cl inica lly and histologica lly d iag-
nosed CT CL, incl uding 16 patients with MF, 3 patients with Sezary 's 
syndrome (SS), i patient with a T-cell leukemia with the cl inical 
features of SS but without circulating Sezary cells, and 1 patient with 
pagetoid reticulosis, d isseminated form. The second group comprised 
14 patients with benign inflam matory dermatoses, selected because of 
the presence of a bandl ike mononuclear infil trate in the sl' in biopsies. 
This group included [j patients with atopic dermatitis, 4 of whom 
(#22-25) showed genera lized skin disease (atopic erythroderma) , 1 
patient with lichen simplex chronicus, 7 patients with chronic nonspe-
cific dermatitis (chronic eczema) showing generalized or circumscribed 
eczematous skin lesions of unknown origin for more than 6 months, 
and 1 patient with lichen planus. Add itiona lly, in 3 patients with contact 
dermatitis, skin biopsies were taken [rom positive patch tests 72 h r 
after applica tion of the a lle rgens, i. e ., nickel sulfate 2.5% in 2 cases (#37 
and 38) and benzalkon iu m chloride 0.05% in one case (#36). 
T he patients with MF were staged according to the modified Fuks 
classificat ion [1 3]: stage I, MF confined to the skin; stage II , MF wi th 
dermatopathic lymphadenopathy; stage III, MF with lymph node in-
volvement; stage IV, MF with visceral involvement. The type of skin 
lesion is indicated as eczematous (a) , plaque (b), tumor (c), and eryth-
roderma (d) . The patients with stage III MF had been treated with 
polycy tostatic COUl"ses consisting of cyclophosphamide, vincristin (On-
covin), and prednisone (COP) 1-3 years prior to the present investiga-
tion. Only patient # 19 continued to receive COP courses every 6 week 
in combina tion with topical nitrogen mustard, because of incomplete 
remission. T he last COP CO Ul"se was given 5 weeks prior to this study. 
At the time of biopsy, treatment cons isted of systemic steroids in 1 
patient (#4) , topical ni t rogen mustard in 2 patients (#1 a nd 12) , and 
PUVA therapy in another 2 cases (#8 and 17). The remaining 15 
pat ien ts in the CT CL group and all patients with chronic benign skin 
disease had received no treatment other than topical steroids. 
Antisera. 
A panel of monoclonal antisera with well-defined specificities was 
used. These included Leu-I , Leu-2a, Leu-3a, HLA-DR (Becton Dick-
inson, Facs. Systems, S unnyvale, California) , OKT3, OKT4, OKT6, 
OK'1'8, (k indly given by Dr. G. Goldste in, Raridan, New York), and 
TA-1 (kindly given by Dr. J. Kersey). Apart from the 2 monoclonal 
ant ibodies raised against human HLA-DR (la-like) antigens, a mouse-
Ia-alloant ibody (Cedarlane, Canada) which also reacts with human 
HLA-DR a ntigens [14], was used. The specificities of these antibodies 
are given in Table 1. B lymphocytes defined by the presence of surface 
immunoglobulins, were demonstrated by rabbi t a ntisera directed 
aga inst human IgM , and k or l\ light chains (Dakopatts, D enmark). 
Staining of Ti.~sl/.e Sections 
S kin tissue specimens were quickly froze n in liquid ni trogen and 
stored at -70°C. For demonstra tion of antigens reactive with the 
a forementioned monoclonal antibodies a 4-step immunoperoxidase 
technique [28] was used. Sections 6 /lm thick were air dried with a 
venti lator for 60 min, foll owed by acetone fixa t ion at room temperatUl"e 
fo r 10 min. Subseq uently t he sections were stored at -20°C for 30 min, 
a ir ill·ied aga in, and washed in phosphate-buffered sal ine (PBS) , pH 7.2 
for 5 min . Incubation with the primary antibody, at a di lu t ion 1:50-1:100 
fo r all antibodies used, lasted 60 min. The other incubations, subse-
quently rabbit antimou. e Ig serum (Miles Laboratories), swine anti-
rabbit Ig serum in excess (Dakopatts, Denmru·k) , and the peroxidase 
anti peroxidase (PAP) complex prepared in rabbi ts (Dakopatts, Den-
mark) , lasted 30 m in each. The rabbit antimouse Ig antiserum was 
absorbed wi th liver powder twice a nd extensively with human serum Ig 
before use. Between incubations the sec tions were washed with PBS 
for 30 min. T he applica t ion of diaminobenzidine (DAB) 5 mg/ l0 ml in 
Tris-HCI buffer lasted 5 min and was succeec\ed by a quick rinse in 
d isti lled water to remove excess DAB. Finally hematoxylin was used 
for nucleru· staining and the sections were mounted in malinol. Positive 
controls consisted of verification of the primru·y step by indirect im-
munoflu orescence, and application on t issue sections with a ,, ~ .. ·' t1own 
distribut ion of T-ce ll subsets, such as lymph node, tons il , and thym us. 
Negative cont rols consisted of omission of the primru·y, secondary, or 
tertiru·y layer of antibody a nd application of DAB alone. B cells were 
demonstrated by 3-step immunoperoxidase bridge technique using 
swine antirabbit Ig a ntiserum as second layer, fo llowed by incubation 
with the PAP complex, as described above. The percentages of posi-
t ively staining cells were estimated independently by 2 observers (RW, 
CM). 
Peripheral Blood 
The percentates of T ce lls and T-cell subsets in the peripheral blood 
in 25 of 38 patients and 10 healthy donors were determined. Peripheral 
blood lymphocytes were isolated by Fico ll -Hypaque gradient centrifu-
Antibody 
Leu- i 
Leu-2a 
Leu-3a 
OJ('1'3 
OKT4 
OKT8 
OKT6 
TA- J 
OKla J 
HLA-DR 
TABLE L Specificity 0/ monoclona.l antibodies 
Specificity 
95% huma n thymocyt.es, 2:95% peripheral blood T -ce lls, 
some S Ig' CLL cells, but not on normal B lymphocytes 
[1 51-
Cytotoxic/suppressor T-subse t. [1 6, 17] 
Helper/ inducer T-subset [16,171 
100% peripehra l blood T-ce lls, 20% thymocytes [181 
Helper/ inducer T-subset [19,20] 
Cyt.otoxic/suppressor T-subset [19,21] 
70% thymocytes [22]; epiderma l Langerhans ce lls [231 
100% peripheral blood '1'-ce lls, 70% t.hymocytes, 2:95% 
peripheral blood monocytes [24] 
B-Iymphocytes, 1l10nocytes/ macrophages, act.ivat.ed 1'-
cells [251 
B- Iymphocytes, monocyt.es/ l11acrophages, activated T-
cells [26,27] 
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gation of heparinized venous blood, afte r incubation with carbonyl iron 
particles at 37°C for 30 min to remove monocytes. Ce lls were washed 
3 times with PBS supplemented with 10% fetal calf serum (FCS) , and 
subsequently stored in liquid nitrogen in minimal essent ia l medium 
supplemented with 10% FCS and 10% dimethyl su lfoxide until t he time. 
of study. Then a suspension of 40.101; cells/ml was made. Cells (IOu) 
were incubated with the monoclonal antibodies (251'1, dilution 1:20) for 
30 min at 4°C, washed twice in PBS, a nd subsequently incubated with 
25 1'1 fluorescein-conjugated goat anti mouse serum (GAM/FITC, 
Nordic Immunological Laboratories, Tilburg, The Netherlands) at a 
d ilu tion of 1:50 for 30 min a t 4°C. At least 200 lymphocytes were 
counted using a Leitz orthoplan fluorescence microscope with epi-
illuminator to determine the percentages of positive ce lls . The percent-
age of T ce lls was also determined by spontaneous rosette formation 
with neUl'amidase-treated uncoated sheep e rythrocytes (EN) [29]. Lym-
phocytes bearing surface immunoglobulins were de termined as de-
scribed by Jansen et a l [30]. 
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RESULTS 
The results in the patients with CTCL and with benign 
inflammatory dermatoses are summarized in Tables II and III 
respectively. Control sections incubated with PBS in place of 
specific antibodies showed only nonspecific staining of occa-
sional neutrophils, mast cells, and eosinophils, which were often 
numerous in cases of atopic dermatitis. In all cases staining for 
IgM, k or A light chai ns showed only occasional positive cells, 
indicati ng that the number of B lymphocytes in the cutaneous 
infil trates studied is negligible. The percentages ofLeu-2a+ and 
Leu-3a+ cells were always comparable with the number of 
OKT8+ and OKT4+ cells, respectively, suggesting that these 
antisera define closely related antigens. However, staining with 
OKT4 antiserum generally was less intense than staining with 
th e other antibodies. In the cutaneous infiltrates, the localiza-
TABLE II. Percentages of T -cell subpopu[ations in the dermal infiltrates and p eripheral blood of patients with cutaneolls T -cell lymphomas 
Skin" Peripheral Blood /, 
Case Diagnosis OKT4/ OKT8/ OI< la l/ OKT4/ 0I{T8 Ol<la I / Leu-I TA-I 01<'1'6" E II 01<'1'3 OKT4 OKT8 Sig" Leu-3a Lcu-2a I-ILA-DR N ralia HLA-DR 
1. Sezary's sy ndJ'ome 90 90 10 90 80 ± 10 87 85 1 >30 ND ' ND 
2. Sezary's syndrome 90 90 5 90 75 ± 71 94 95 3 >30 5 2 
3. Sezary's syndrome 90 SO 15 60 50 ± 76 96 93 3 >30 2 4 
4. T-cell leukemia 90 10 90 SO 50 ++ 76 95 28 71 0.4 22 11 
5. MF (Ia) 70 50 25 70 90 +++ 
6. MF (I b) 60 60 10 60 40 ++ 
7. MF (Ib) SO 75 20 55 65 +++ 
S. MF (Ib) SO 70 25 SO 60 ++ SI 72 42 13 3.2 II 11 
9. MF (Ic) 10 SO 5 ND 40 +++ 71 78 60 24 2.5 16 
10. MF (Ic) 30 40 25 40 50 ++ 77 55 25 25 1.0 17 21 
11. MF (Ic) 30 40 20 30 90 ++ 
12. MF (lIb) 40 50 30 50 50 ++ SO 76 5S 26 2.2 ND 22 
13. MF (IIb) 60 50 10 50 SO +++ 73 67 55 II 5.0 4 6 
14 . MF (IIIb) 50 40 15 ND 60 +++ 
15. MF (IIIb) 50 40 20 ND 30 + 75 76 62 26 2.4 20 20 
16. MF (IlIc) 10 SO 5 ND SO +++ 6S 70 35 L4 2.5 30 2S 
17. MF (IIIc) SO 75 20 80 65 ++ 
LS. MF (IlIc) 40 70 15 30 50 +++ 76 75 54 27 2.0 16 II 
19. MF (IIIc) 60 20 5 30 30 ++ 64 43 2S 17 1.7 15 15 
20. MF (IVc) 80 50 5 SO 40 +++ 58 42 25 19 1.3 ND ND 
2 1. Pageto id re ticulosis 40 40 25 40 50 ++ 70 56 40 27 1.5 13 16 
" The resu lts in the skin represent estimated values. 
" The results in the peripheral blood represent percentages of the tota l lymphocyte populations. 
,. The results for OKT6 are expressed as number of ce lls/HPF 400x: ±, 1-5 cells; +, 5-10 ce lls; ++, 10-20 ce lls; +++, >20 ce lls . 
" EN: percent.age of total lymphocytes forming rosettes with neuramidase-treated sheep erythJ'ocytes. 
,. Percentage of lymphocytes bem'ing surface Ig. 
' ND = not done. 
TABLE III. Percen.tages of T -cell slIbpoplllations in the derm.al infiltrates and peripheral blood of patients with ben.ign. inflam.matory 
derm.atoses 
Skin" Peripheral Blood " 
Case Diagnosis 01<'1'4 / OKT8/ OKlal / OK1'4/0KT8 OK la]/ Lcu- I Leu-3a Leu-2a TA-l HLA-DR 01<'1'6" EN
1/ 01<1'3 01{T4 OKT8 ratio HLA-DR Sig" 
22. Atopic dermatitis 50 70 10 30 50 ++ 76 76 57 21 2.7 10 14 
23. Atopic dermatitis 40 55 5 25 60 ++ 72 8] 68 11 G.2 NO ' 13 
24. Atopic dermatitis SO 50 40 70 50 + 76 S5 69 20 3.5 16 17 
25. Alopic dermatitis 70 50 30 50 SO ++ 64 67 55 11 5.0 8 ND 
26. Atopic dermatitis 50 40 ]5 ND 50 ++ 64 69 50 24 2. 1 17 22 
27. Lichen simplex chropicliS 70 60 15 60 60 ++ 
28. Chronic eczema 70 50 25 75 50 + 74 76 52 24 2.2 14 L4 
29. Chronic eczema 70 50 20 60 40 + 74 82 5] 25 2.0 20 10 
30. Chronic ecze ma 60 50 10 ND 50 ++ 67 6S 49 25 2.0 13 16 
31. Chronic eczema 60 40 25 NO 70 ++ 78 70 50 L9 2.6 14 13 
32. Ch ronic eczema fiO 40 20 NO 50 ++ 70 86 69 21 3.3 19 19 
33. Chronic eczema 60 50 15 ND 50 ++ 
34 . Chronic eczema 60 50 20 ND 40 ++ 
35. Lichen planus SO 90 5 60 60 ++ 
36. Contacl dermalitis 90 80 10 80 20 ± 
37. Contact dermatitis 90 75 20 85 20 ± 
3S. Contact dermatitis 90 75 20 S5 20 ++ 
Hea lthy donors (n = 10) 72.2 76.0 51.3 25. 1 2. 1 12.3 12.4 
±4.7 ±6.0 ±6.3 ±3.4 ±0.4 ±2.2 ±5.4 
For legends see T able II. 
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FIG 1. Dermal infil trate of patient with SS (case #3). a, Large 
clusters of ce lls reactive with Leu-3a (T helper/ inducer phenotype). 
Immunoperoxidase, X 64 . b, Diffusely distributed Leu-2a+ cells (T 
cytotoxic/suppressor phenotype). Immunoperoxidase, X 64. 
FIG 2. Dermal infil trate of patient with T-cell leukemia (case #4). 
Note many dendritic cells, intensely staining with OKT6 antiserum 
(presumably Langerhans cells), scattered among the neoplastic T cells. 
lmmunoperoxidase, X 80. 
t ion patterns of Leu-3a+ or OKT4+ cells and of Leu-2a+ or 
OKTS+ differed considerably. Whereas Leu-3a+, OKT4+ cells 
tended to form large clusters, Leu-2a+, OKTS+ cells were dif-
fusely scattered or localized at the periphery of the infiltrate. In 
the case of epidermal infiltration by mononuclear cells, both T -
cell subsets were found in t he epidermis. Identical ce ll popula-
tions were stained by the anti-HLA-DR and OKIal a ntisera. 
Sezary's Syndrome (n = 3) 
In a ll 3 cases approximately 90% of the cells in the skin were 
reactive with Leu-I, Leu-3a, OKT4, and TA-l antisera (Fig la). 
The percentage of Leu-2a+, OKTS+ cytotoxic/ suppressor cells 
was very low (5-15%) (Fig Ib). OKT6+ dendritic cells which 
presumably represent La ngerhans cells were found in the epi -
dermis and occasionally in the dermal infiltrate. In the skin, 
large numbers of nondendritic cells expressed HLA-DR (Ia-
like) antigens. T he predominance of T lymphocytes a nd the 
absence of Slg+ cells suggest that these cells are activated T 
cells. By contrast, in the peripheral blood, which showed a 
proliferation of OKT3+, OKT4+ cell , the number of HLA-DR+ 
cells was not increased. In one case (#1) the neoplastic cells 
had lost theij' ability for E-l'osetting, but retained their OKT3 
and OKT4 a ntigens. 
T-cell Leuhemia (n = 1) 
In the skin and the peripheral blood of this patient, who 
presented with all the cl inical features of SS but without 
circulating Sezary cells, a predominance of Leu-2a+, OKTS+ T 
cytotoxic/ suppressor cells was found. The dermal inftltrate 
contained many OKT6+ dendritic cells (approximately 20/ HPF 
400x), scattered among the lymphoid cells (Fig 2). About 50% 
of the cells in the skin expressed HLA-DR antigens. Many of 
these HLA-DR+ cells were clearly dendritic and probably rep-
resent cells of the Langerhans cell-interdigitating reticulum cell 
series. T he percentage of HLA-DR+ cells in the peripheral 
blood was also increased. 
Mycosis Fungoides (n = 16) 
In all 16 cases with MF a predominance of Leu-3a+, OKT4+ 
ce lls was found (Fig 3a). The percentage of Leu-2a+, OKTS+ 
cells, which ranged from 5-30%, tended to decrease with increas-
ing severity of the disease. Moreover, in the cutaneous infil-
trates of patients with advanced disease many, often blastlike, 
cells were found which were unreactive with Leu-l (#9, 12, 16, 
and IS), with Leu-3a or OKT4 (#19 and 20) or with all 3 
antisera (#10, 11, 14, and 15). Vru'ying numbers of dendl'itic 
OKT6+ cells were found both in the epidermis and in the 
dermal infiltrate (1-20 or more/ HPF 400x) (Fig 3c). Staining 
with the anti-HLA-DR and OKIal antisera showed Jru'ge num-
bers of cells expressing l a- like antigens in all cases. Although 
FIG. 3. Dermal infiltrate in patient 
with advanced stage MF (case #10), 
stained with anti-Lell-3a (a), anti-HLA-
DR; (b) , and OKT6 antiserum (c). Not.e 
that the nwmerous dendritic HLA-DR+ 
cells are SUlTollnded by unstained lym-
phoid cells. In this case few nondendJ'i tic 
HLA-DR+ lymphoid cells were observed. 
Immunoperoxidase, a and b x 50, c x 63. 
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many of t hese cells were clearly dendritic, varying numbers of 
nonden<hitic HLA-DR+ cells, suggestive of activated T-cells, 
were also fou nd (Fig 3b) . In contrast, the percentage of HLA-
DR", Slg- cells in th e peripheral blood was not increased. The 
distribution ofT-ceil subsets in the peripheral blood, which was' 
investigated in 10 of 16 patients, was completely normal in 4 
patients (#9, 12, 15, and IS) as compared to the control group. 
In 1 patient with widespread skin lesions (#13) a decreased 
percentage of OKTS+ cells was found, resulting in an increased 
OKT4/0KT8 ratio. In the peripheral blood of patients with 
advanced disease many OKT3- , OKT4- , OKT8- (# 10, 19, a nd 
20) or OKT3+, OKT4- , OKT8- (#8 a nd 16) cells were found . 
Pagetoid Reticulosis, Disseminated Form (n = 1) 
At most 60% of t he cells of the intraepidermal infIltrate 
stained for th e different anti-T-cell antise ra. Approximately 
50% of the cells expressed la-like antigens. The m ajority of 
these cells were dendritic. The percentage of dendritic OKT6+ 
cells was about 5%. In the peripheral blood low percentages of 
OKT3+ and OKT4+ cells were found . 
Atopic Dematitis (n = 5) 
In the dermal infiltrates of all cases a predominance of Leu-
3a+ and OKT4+ cells and high percentages (50-80%) of both 
dendritic and nondendritic HLA-DR+ cells were observed. Two 
of the patients with atopic erythroderma (#22 and 23) showed 
very low num bers (5-10%) of Leu-2a+, OKTS+ cells, which 
correlated with extremely high IgE levels (> 10,000 E/ml) and 
very low percentages of T lymphocytes bearing an Fc receptor 
for IgG (Ty) in the peripheral blood (data not shown). In all 
cases but one (#24) many dendritic OKT6+ cells were found 
both in the epidermis and in th e dermal infiltrate. The periph-
eral blood of the 4 patients with atopic erythroderma showed 
increased OKT4 values a nd decreased OKTS values, resulting 
in a significantly increased OKT4/0KT8 ratio, whereas patient 
#26, wh o h ad only a few lesions, showed a completely normal 
distribution. The percentages of HLA-DR+, Slg- cells in th e 
peripheral blood were not increased as compared to the results 
in the control group. 
Lichen Simplex Chronic us (n = J) and Chronic Eczema (n = 
7) 
The bandlike mononuclear infiltrate of these 8 patients 
showed a nearly identical distribution of lymphoid and dendritic 
cells: Leu-I '· cells, 60-70%; Leu-3a+, OKT4+ cells, 40-60%; Leu-
4a ~ 
J - . _ 
. ~ _' --.. _ .... " .. _ .. _.JY;_ 
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FIG 4. Contact dermatitis. Large numbers of Leu-l + T ce LI s (a) and 
many in tensely s ta ining dendritic HLA-DR+ ceLis interspersed a mong 
the lymphoid cells (6). Immunopel'Oxidase, X 64. 
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2a+, OKTS+ cells, 10-20%; HLA-DR+ cells (both dendritic and 
nondendritic), 40-60%; and OKT6+ cells, 5-15 cells / HPF 400x. 
Characterization ofT-ceil subsets in the peripheral blood, which 
was investigated in 5 patients, showed a normal distribution in 
all but one (#32). This patient with generalized skin lesions 
showed an increased percentage of OKT4 + cells a nd a n elevated 
OKT4/0KT8 ratio. 
Lichen Planus (n = 1) 
The large majority of the lymphoid cells showed posit ive 
staining with Leu-I, Leu-3a, OKT4, and TA-1 a ntisera, whereas 
only occasional cells reacted wit h Leu-2a and OKTS antisera. 
Approximately 60% of the lymphoid cells expressed HLA-DR 
antigens. The number of dendritic cells reactive with a nti -HLA-
DR, OKlal, or OKT6 a ntisera was very low. 
Contact Dermatitis (n = 3) 
In all 3 cases approxinlately 90% of the cells reacted with 
Leu-l and TA-1 antisera, 75% with Leu-3a and OKT4 an tisera 
(Fig 4a), whereas the number of cells reactive with Leu-2a a nd 
OKTS a ntisera varied between 10-20%. HLA-DR antigens were 
exclusively expressed by dendritic cells (10-15%) (Fig 4 b). Den-
dritic OKT6+ cells were very scarce in the epidermis, normally 
distributed in the adnexal epithelium, and less frequent in the 
derma l infiltrate as compared to the HLA-DR+ dendritic cells . 
DISCUSSION 
In the present study the distribution of T-cell subpopulations 
in the skin and the peripheral blood of 21 patients with CTCL 
was compa red with that of 14 patients wi t h chronic benign skin 
diseases, histologically characterized by a bancllike mononu-
clear infil trate. In SS an expanded population of OKT3+, 
OKT4+, Leu-l+, Leu-3a+, and TA-l+ cells, a nd extremely low 
percentages of Leu-2a+, OKTS+ cells were found both in t he 
skin and th e peripheral blood, which is consistent with recent 
find ings of other investigators [31,32]. 
The distribution of T-cell subpopulations in the skin a nd 
peripheral blood in patients with MF varied with the clinical 
stage of the disease. In all cases t he cutaneous infil t rates showed 
a predominance of Leu-3a+, OKT4+ cells, bu t t he number of 
Leu-2a+, OKTS+ cytotoxic/suppressor T cells showed consid-
erable variation and tended to decrease with increasing severi ty 
of the disease. Moreover, in the dermal infiltrate and in th e 
peripheral blood of patients wit h advanced disease many, often 
blastlike, cells were observed which did no t show the pan T-
cell (Leu-l+, OKT3+) and /or h elper/inducer T cell (Leu-3a+, 
OKT4"' ) pheno type. Probably the neoplastic cells in MF loose 
one or more of these antigens during the progression of the 
disease. T he loss of T-cell markers in the advanced stages of 
MF has been described previously [33,34] a nd has been found 
to correlate with a poor prognosis [34]. However, the prognostic 
significance of the loss of reactivity with these monoclonal T-
ceJl antisera remains to be determined on a larger group of 
pat ients with a longer follow-up period. 
111 both MF and SS the dermal infiltrate contained large 
numbers of cells reactive with the anti-HLA-DR and OKIa1 
antisera, whereas the percentage ofHLA-DR+, S1g- cells in the 
peripheral blood was not increased . In the 3 cases of SS these 
HLA-DR antigens were predomina ntly expressed by nonden-
drit ic lymphoid cells, probably representing activated T-cells 
[25). By contrast, the dermal infiltrate in MF showed, apar t 
from activated T cells, many dendritic nonlymphoid cells which 
stained in tensely with the anti-HLA-DR a ntisera. These cells 
are probably not of lymphoid origin, but rather part of t he 
La ngerhans cell-interdigitating reticulum cell series [2S,35]. 
Similarly, in MF considerable numbers of dendri t ic cells reac-
tive with OKT6 antiserum which presuma bly represent Lan-
gerhans cells [23] were found scattered among the lymphoid 
cells, whereas these cells were on ly occasionally observed in the 
dermal infiltrate in SS. The presence of OKT6+ Langel'hans 
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cells in t h e derma l infi ltrate of MF has been r eported very 
recently by oth e r g ro ups [36-38]. The presence of T lymp ho-
cytes expressing HLA-DR a n t igens in large-plaqu e parapso-
riasis [39] a nd SS [31] has been s uggested to be indicative of 
malignant t r a nsformation. However, this seems unlike ly since 
large number s of HLA-DR+ cells were a lso observed in lic h en 
p la nus (#25) , which is consisten t with previo us findings of 
Tjernlund [40]. The predominance of Leu-3a+, OKT4+ cells in 
lic h en planus has a lso been reported by McMillan et a l [41]. 
Analysis of t h e cu taneous infiltrate in patients with atopic 
derma titis a nd chro nic eczema sh owed a s imilar distribution of 
T-cell subsets, HLA-DR+, a nd OKT6+ cells as compared to t he 
early stages of MF. A nalysis of t h e peripheral b lood in t h ese 
patients sh owed a n imba la nce in th e distribution of OKT4 and 
OKT8 subsets, resu lting in a n increased OKT4/ 0KT8 ratio in 
t h e 4 patients with atopic erythroderm a a nd in 1 patient (#32) 
wit h gen eralized chronic eczema. A s imilar distribution of T-
cell s ubsets was fo und in 1 patient with MF with widespread 
skin lesio ns (#13). 
In t h e 3 patients with con tact d ermatitis it was re m arkable 
t h at t h e HLA-DR a n t igens wer e expressed o nly by dendritic 
cells, which co n trasts w ith t h e findings in MF, atopic d ermati t is, 
a nd chron ic ecze ma. The a bsen ce of activated T cells in these 
3 patients might be du e to the s h o rt interval between applica-
t ion of t h e allergen a nd th e time of b iopsy. Investigation of skin 
b iopsy spec ime ns from well-esta blis h ed contact dermatitis of 
long dmation will be n eeded to a nswer t his q uestio n. 
The r esul ts of the prese n t study s howing a s imilar distribu t ion 
of T-cell subsets, HLA-DR", a nd OKT6+ cells in t h e s kin a nd 
t h e peripheral blood of patients with ear ly MF a nd chronic 
benign skin diseases indicate t hat t he m on oclona l a n t i-T-cell 
antibodies used in th e present study do not provide additional 
differe n t ia l d iagn ostic c riteria to facili tate the diagnosis of early 
MF. However, t he loss of reactivity with certain a n t i-T-cell 
a n t isera obse rved in t h e advanced stages of MF m ay h ave 
prognostic s ig nifi cance in patie n ts with well-establish ed MF. 
Moreover, t hey may con tribu te to a better understanding of the 
pathogenetic mechanisms involved in MF. Whether MF is a 
cuta neous T-cell lymphoma from the very o u tset or whether it 
starts as a r eactive process is a m atter of considerable debate 
[42,43]' The similar resu lts in early MF, atopic de rmatitis, a nd 
chronic eczema, a nd par t icula rly t h e presence of lru'ge numbe rs 
of dendrit ic HLA-DR+ cells a nd many OKT6+ Langerhans cells 
which are known to have a n a n t igen-presen t ing role, s upport 
the view t h at MF m ay sta r t as a r eactive process, t hat even-
t ually progr esses to frank m a lign a n cy [42]. 
REFERENCES 
1. Bru baker D , Wh iteside TL: Localization of human T -lymphocytes 
in ' t issue sections by a rosetting technique. Am J Pathol 
88:323-332, 1977 
2. Bjerke J R, Krogh HK: Identif'ication of mononuclea r cells in situ 
in skin lesions of lichen pla nus. Br J Dermatol 98:(i05-61O, 1978 
3. Hovmark A: Acid alpha naphtyl acetate esterase sta ining of T-
lymphocytes in human skin. Acta D erm Venereol (Stockh ) 
57:497-502, 1977 
4. Sterry W, Steigleder G, P ullman H: In situ identification and 
enumeration of T · lymphocytes in cuta neous T -cell lymphomas 
by demonstratio n oC granula r activ ity of ac id non-specifi c ester-
ase. Br J Derma to I 103:67-72, 1980 
5. Chu AC, MacDonald DM: Identi fica tion in situ of T · lymphocytes 
in dermal and epiderma l infi lt rates of' mycosis f'ungoides. Br J 
Dermatol 100:177- 182, 1979 
Attempts to en hance lIght mIcroscopIc diagnosis of cuta neous '1'-
cell lymphomas (mycosis fungoid es) . Arch DermatoI 1l7:408-411, 
1981 
I I. Va n Vloten WA, Schaberg A, Van del' P loeg M: Cytop hotometric 
studies on mycosis fun go ides and other reticuloses. Bull Cancer 
(Paris) 64:249-258, 1977 
12. Meyer CJLM, Van del' Loo EM, Van Vloten WA: Ead y d iagnosis 
of mycosis fungoides and Sezary's syndrome by morphometric 
a nalysis of lymphoid ce lls in the skin. Cancer 45:2864-2871, 1980 
13. Fuks ZY, Bagshaw MA, Farber EM: Prognostic signs and the 
management o f' mycosis fungo ides. Cancer 32:89- 106, 1973 
14. Lunney JK, Mann DL, Sachs DH: Shru' ing of Ia a nt igens between 
species. III. Ia specificities shared between mice and human 
beings. Scand J Immu nol 10:403-408, 1979 
15. Wang CY, Good HA, Ammil·at.i P , Dymbor t G, Evans HL: Identi-
fication of a p69? 71 complex expressed on human T-cells shru'ing 
detenl1lnants WIth B-type chromc lymphatic leukemic cells. J 
Exp MedI51:1539-1544 , 1980 
16. Ledbetter JA, Evans HL, Lipinski M, Rundles C, Good HA, Her-
zenberg LA: Evolu tionary conservation of surface mo lecules that 
distinguish T·lymphocyte helper/inducer a nd cytotoxiC/suppres-
sor subpopu lat ions in mouse a nd man. J Exp Med 153:310-323, 
1981 
17. Evans HL, Wall SW, P latsoucas CO, Siegal FP, Fihig SM, Testa 
CM, Good RA: Thymus-dependent membrane ant igens in man: 
inhibi tion of ce ll mediated lympholysis by monoclona l a ntibodies 
to '1'H2 a ntigen. Proc Natl Acad Sci USA, 78:544-548 1981 
18. Kung PC, Goldstein G, Reinherz EL, Schlossman SF: Monoclona l 
a ntibodies defin ing distinctive human T-cell surface a ntigens. 
Science 206:347-349, 1979 
19. Reinherz EL, Kung PC, Go ldstein G, Schlossman SF: Separation 
of functional subsets of human T-cells by a monoclona l antibody. 
P roc Natl Acad Sci USA 76:4061-4065, 1979 . 
20. Heinherz EL, Kung PC, Goldstein G, Schlossman SF: Fu rther 
cha racteri<!:ation of the huma n indu cer T-cell subset defined by 
a monoclonal antibody. J Immunol 123:2894- 2896, 1979 . 
2 I. Reinherz EL, Kung PC, Goldste in G, Schlossman SF: A monoclonal 
antibody reactive with t he huma n cyto toxic/suppressor T-ce ll 
subset previously defined by a heteroantiserum termed TH2. J 
ImmunoI 124:1301-1307, 1980 
22. Heinherz EL, Kung PC, Goldstein G, Levey HH, Sch lossman SF: 
D iscrete stages of human in trathymic differentiation: analy is of 
norma l thymocytes and leukem Ic lymphoblasts ofT lineage. Proc 
Nat! Acad Sci USA 77:1588- 1592, 1980 
23. Murphy GF, Bhan AK, Sato S, M ihm MC Jr, Harris!. TJ : A new 
immunologic ma rker for human Langerhans cells. N Engl J Med 
304:79 1-792, 1981 
24 . LeB ien '1', Kersey JH: A monoclonal antibody (TA-1) reactive with 
human T- lymphocytes and monocytes. J Immunol 125: 
2208-2214, 1980 
25. Heinherz EL, Kung PC, Pesando JM, Ritz J, Goldstein G Schl oss-
man SF: la det;erminants on huma n T-cell subsets d~fined by 
monoclona l ant.tbody. ActivatIOn stlmuh reqLllred for expression. 
J Exp Med 150: J472- J482, 1979 
26. Warnke H, Levy R: Detection of '1'- and B-cell antigens with 
hybl'Odoma monoclona l a nt ibodies: a biot.in·av idin-horseradish 
pel'Oxidase method . J H istochem Cytochem 28:771-776, 1980 
27. Warnke H, Miller R, Grogan R, Pederson M, Dilley J, Levy R: 
Immunologic phenotype in 30 patients with diffuse large' cell 
lymphoma. N Engl J Med 303:293-300,1980 
28. Poppema S, Bhan AK, Reinherz EL, McCluskey RT, Schlossman 
SF: Distribution of T-cell subset.s ill human lymph nodes. J Exp 
Med 153:30-41, 1981 
29. Van de l' Putte LBA, Meijer CJLM, Lafeber CJM, Kleinjan R Cats 
A: Lymphocytes in rheumatoid a nd non-rheumatoid sYI;ovial 
fl uid . T he non-specificity of' high T-cell and low B-cell riercent. 
ages. Ann R heum Dis 35:451-455, 1976 
30. Jansen J, Schuit HRE, Zwet TL, Meijer CJLM, Hijma ns W: Ha ir y-
cell leukemia: a B-lymphocytic disorder. Br J HaematoI 42:21-33, 
1979 
31. Kung PC, Berger CL, Goldstein G, LoGerfo P, Edelson RL: Cuta-
neous T-cell lymphoma: characte rization by monoclonal anti-
bodies. Blood 57:261-26(;, 1981 
:32. Haynes BF, Metzga r RS, Minna JD, Bunn PA: P henotype char-
acte ri zation of cut.aneous T-cell lymphoma. Use of monoclonal 
antibod ies to co mpar e with other malignant T-cells. N E ngl J 
Med 304:1319-1323, 1981 
6. Schmi tt D, Alario A, Thivolet J : In s itu characterization of tissue 
ce lls of cutaneous infil trates using specific membrane a ntigens. 
Clin Exp DermatoI 4:lG1-174, 1979 
7. Ch u AC, Morgan EW, MacDona ld DM: Evaluation of acid a lpha-
naphty l acetate esterase act ivity a. a marker of T-lymp hocytes 
in benign and neoplastic cutaneous in fil t rates. Br J Dermatol 
L04:31-36, 1981 
33. Nordqvist BC, Kin nay JD: 1'- and B·ce lls and cell med iated im-
mu ni ty in mycosis fu ngoides. Cancer 37:714-718, 197(; 
8. Edelson HL: Cutaneous T-ce ll lymphomas-perspective. Ann Intern 
Med 83:548-552, 1975 
9. Clendenning WE, Rappaport HW: Hepor t of the commi tt.ee on 
pathology of cutaneous T -cell lymphomas. Cancer Treat Rep 
63:719-72 1, 1979 
10. Lefeber WI-', l-{obinson ~K , Clendenning WE, Du nn JL, Co lto n 1': 
34. Van del' Loo EM, Meijer CJLM, Scheffer E, Van Vloten WA: The 
prognostic va lue of membrane mru'kers and morphometric char-
act.eristics of lymphoid cells in blood and lymph nodes from 
patients with mycosis fungoides. Cancer 48:738-744, 1981 
35: Janossy G, Duke 0 , Pou lter LW, Panayi G, Bofil l M, Go ldste in G: 
Hheumatoid arthri t is: a disease of T-lymphocyte/ macl'ophage 
immunol'egulation. Lancet 2:839-842, 1981 
36. Turbitt ML, MacKie RM: Further evidence for the involvement. of 
Langerhans cells in the pathogenesis of mycosis fungoides. Br J 
66 KOBA Y ASHI AND HASHIMOTO 
Dermatol 105(suppl):1l-1 2, 1981 
37. Chu A, Kung P, Edelson R: Dermal Langerhans cells in cutaneous 
lymphoma. An in situ study using monoclona l ant ibod ies (abstr) . 
J Invest Dermatol 76:324, 1981 
38. Thomas JA, Janossy G, Graham-Brown RAC, Kung PC, Goldstein 
G: The relationsh ip between T-Iymphocyte subsets and la- like 
ant igen posit ive nonlymphoid cells in early s tages of cutaneous 
T cell ly mphoma. J Invest Dcrmatol 78:1 69-176, 1982 
39. McMillan EM, Wasik R, Everett MA: HLA-DR positive ce lls in 
large plaque (atrophic) parapsoriasis. J Am Acad Dermatol 
5:444-449, 1981 
0022-202X/ 83/ 800 1-0066$02.00/ 0 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY , 80:66-72, 1983 
CopYl'ight © 1983 by The Williams & Wilkins Co. 
Vol. 80, No.1 
40. ' I'jerlund U: Beta-2-microglobulin a nd HLA-DR (la) antigens in 
normal and pathological skin. Acta Derm Venereol [Suppl] 
(Stockh) 94, 1981 
41. McMillan EM, Martin D, Wasik R, Everett MA: Demonstration in 
s itu of T-ce lls and T-cell subsets in lichen planus using monoclo-
nal antibodies. J Cutan Pathol 8:228-234, 1981 
42. MacKie RM: Initial event in mycosis fungo ides of the s kin is viral 
infection of epidermal Langerhans cells. Lancet 2:283-285, 1981 
43. Norris DA: The pathogenesis of mycosis fun goides. Clin Exp Der-
matol 6:77-87, 1981 
Vol. 80, No.1 
Printed in U.S.A . 
Amyloidogenesis in Organ-Limited Cutaneous Amyloidosis: An 
Antigenic Identity Between Epidermal Keratin and Skin Amyloid 
HITOSHI KOBAYASHI, M.D. AND KEN HASHIMOTO, M.D. 
DepartmeJit of Dermatology an.d Syphilology, Wayn.e State University School of Medicine, Detroit, Michigan, U.S.A. 
Epidermal keratin was extracted and antibody against 
this protein was produced in rabbits. Various forms of 
organ-limited cutaneous amyloidosis (lichenoid, macu-
lar, and nodular amyloidosis, and basal cell epithelioma) 
and primary systemic amyloidosis were immunohisto-
chemically examined to test the identity between epider-
mal keratin and skin amyloid. 
Amyloids in lichenoid and macular amyloidoses, and 
in basal cell epithelioma had an identical antigenicity 
with epidermal keratin, whereas amyloids in nodular 
amyloidosis and systemic amyloidosis did not have this 
identity. In addition, amyloid in lichen amyloidosis con-
tained disulfide bonds as in keratin. Connective tissue 
components including filaments of fibroblasts a~d vas-
cular endothelial cells did not react with this antikeratin 
antibody. It was concluded that at least some of the 
amyloid substance in organ-limited cutaneous amyloi-
dosis is derived from degenerated epidermal keratino-
cytes through filamentous degeneration or apoptosis. 
Among various forms of amyloidosis occurring in the skin, 
such ,as primary systemic amyloidosis, secondary systemic amy-
loidosis, familial systemic amyloidosis, and organ-limited cuta-
neous amyloidosis, the organ-limited cutaneous · amyloidosis 
appears to be a distinct entity. This entity distinguishes itself 
because (1) it is not related to any systemic diseases [1,2], (2) 
amyloid deposition is always limited in subepidermal area, and 
(3) sometimes it is found even within the epidermis [3]. It has 
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been suggested by several investigators that the epidermis may 
participate in the pathogenesis of organ-limited cutaneous amy-
loidosis [4,5]. Recently, we reported that in various forms of 
organ-limited cutaneous amyloidosis degenerated epidermal 
cells drop off into the dermis instead of normally migrating 
upward to the skin smface, and we postulated that those 
degenerated epidermal cells contribute to the formation of skin 
amyloid [6-9]. Ultrastructurally, tonoftlaments in degenerating 
epidermal cells sequentially change their featmes ("ftlamentous 
degeneration") and become morphologically identical to amy-
loid filaments [6-9]. 
Recent biochemical studies on keratin have clarified that 
epidermal keratin consists of a number of polypeptide subunits 
which are referred to epidermal fibrous protein or keratinous 
protein [10,11). Furthermore, it has been shown that keratin 
ftIaments can be assembled in vitro from this group of polypep-
tides or form a mixtme of purified monomers [12,13]. Recent 
progress in pmification procedure of keratin made it possible to 
produce specific antibody and to demonstrate that it is t he 
tonofilaments of epidermal cells that express the antigenicity of 
pmified epidermal keratin [14-16). 
In the present study we pmified this epidermal keratin and 
produced antiserum in rabbits. Amyloid tissues from organ-
limited cutaneous amyloidoses (including lichenoid, macular, 
and nodular amyloidoses, and amyloid associated with basal 
cell epithelioma) and primary systemic amyloidosis (AL amy-
loid) were immunohistoch emically tested using the antiserum 
thus produced to determine whether any antigenic relationship 
exists between skin amyloid and epidermal keratin. 
MATERIALS AND METHODS 
Amyloid Tissues 
Six biopsies were obtained from 3 patients with lichen amyloidosis, 
2 biopsies from 2 patients with macular a myloidosis. In addition, 1 
biopsy from a patient with basa l cell epithelioma, 1 biopsy each from 
2 patients with nodular a myloidosis, and skin and heart tissues from an 
autopsied patient with primary systemic amyloidosis were obtained. 
Either freshly frozen sections or formalin-fixed paraffin sections were 
cut at 4 lim and used for the following immunohistochemical stainings. 
The presence of amyloid was always confirmed by Congo red and 
crystal v iolet stainings on serially cut sections. For immunoelectron 
microscopic procedures, specimens were fixed in 4% paraformaldehyde 
